Skip to content
Stocks News
Enter Ticker Symbol
  • Home
  • FEATURED COMPANY
  • ANALYST COVERAGE
  • NEWS
  • SUBSCRIBE
  • CONTACT

ANALYST COVERAGE

wolfe-maintains-outperform-on-roche-holding-ag-(rhhby)-feb-26,-2026

Wolfe Maintains Outperform on Roche Holding AG (RHHBY) Feb 26, 2026

Mar 2, 2026

On Feb 26, 2026 Wolfe Research maintained an Outperform on Roche Holding AG, the key fact driving today’s…

Read more
jefferies-maintains-hold-on-arhaus,-inc.-(arhs)-feb-26,-2026

Jefferies Maintains Hold on Arhaus, Inc. (ARHS) Feb 26, 2026

Mar 2, 2026

On February 26, 2026, Jefferies maintained a Hold on Arhaus, Inc. (ARHS), the latest entry in the ARHS…

Read more
wolfe-maintains-outperform-on-q-(qnity-electronics,-inc.)-feb-26,-2026

Wolfe Maintains Outperform on Q (Qnity Electronics, Inc.) Feb 26, 2026

Mar 2, 2026

On February 26, 2026 Wolfe Research maintained Outperform on Q and raised its price target to $134. The…

Read more
wall-street-analysts-see-synopsys-(snps)-as-a-buy:-should-you-invest?

Wall Street Analysts See Synopsys (SNPS) as a Buy: Should You Invest?

Mar 1, 2026

Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision…

Read more
evercore-maintains-outperform,-pt-$45-for-edgewise-therapeutics-(ewtx)-feb-2026

Evercore Maintains Outperform, PT $45 for Edgewise Therapeutics (EWTX) Feb 2026

Feb 28, 2026

Get analyst ratings, AI forecasts, and market updates in your inbox every morning. 12% average open rate and…

Read more
raymond-james-downgrades-wbd-(warner-bros-discovery-inc.)-to-underperform-feb-2026

Raymond James Downgrades WBD (Warner Bros. Discovery Inc.) to Underperform Feb 2026

Feb 28, 2026

Raymond James downgraded WBD from Outperform to Underperform on Feb 27, 2026. The move is the main shift…

Read more
cowen-maintains-hold-on-monster-beverage-(mnst)-feb-27-2026,-pt-$88

Cowen Maintains Hold on Monster Beverage (MNST) Feb 27 2026, PT $88

Feb 28, 2026

Cowen & Co. maintained a Hold on Monster Beverage Corporation (MNST) on February 27, 2026, and raised its…

Read more
raymond-james-downgrades-ypf-sociedad-anonima-(ypf)-to-neutral-feb-27-2026

Raymond James downgrades YPF Sociedad Anónima (YPF) to Neutral Feb 27 2026

Feb 28, 2026

Raymond James downgraded YPF Sociedad Anónima (YPF) to Neutral on Feb 27 2026, marking the main change in…

Read more
needham-maintains-buy-on-glob,-lowers-price-target-to-$60-feb-27-2026

Needham Maintains Buy on GLOB, Lowers Price Target to $60 Feb 27 2026

Feb 27, 2026

Needham maintained a Buy on Globant S.A. (GLOB) and lowered its price target to $60 on February 27,…

Read more
evercore-isi-maintains-outperform-on-insp-(inspire-medical-systems)-feb-2026

Evercore ISI Maintains Outperform on INSP (Inspire Medical Systems) Feb 2026

Feb 27, 2026

Evercore ISI maintained an Outperform on Inspire Medical Systems, Inc. (INSP) on February 27, 2026, citing that 3…

Read more
cowen-maintains-buy-on-royalty-pharma-plc-(rprx)-feb-27,-2026

Cowen Maintains Buy on Royalty Pharma plc (RPRX) Feb 27, 2026

Feb 27, 2026

Cowen & Co. maintained its Buy rating on Royalty Pharma plc (RPRX) on Feb 27, 2026, while raising…

Read more
the-best-emerging-market-equity-etfs-to-buy

The Best Emerging-Market Equity ETFs to Buy

Feb 27, 2026

Emerging-market stocks can offer diversification for portfolios otherwise devoted to developed markets like Canada and the United States.…

Read more
  1. Pages:
  2. «
  3. 1
  4. ...
  5. 96
  6. 97
  7. 98
  8. 99
  9. 100
  10. 101
  11. 102
  12. ...
  13. 451
  14. »

Posts pagination

Newer posts Page 1 … Page 99 … Page 451 Older posts

The content presented on this site is intended solely for entertainment purposes and should not be construed as an invitation to engage in the purchase or sale of securities. Each content provider featured on 10x Wealth Report brings a unique perspective and predisposition, which may not necessarily align with that of 10x Wealth Report. It is crucial to recognize that 10x Wealth Report is not a registered financial advisor or firm. Read More full disclaimer

CATEGORIES

  • FEATURED COMPANY
  • NEWS
  • ANALYST COVERAGE
  • Special Post
  • CONTACT
  • SUBSCRIBE
  • Privacy Policy
  • Terms or Service
  • Disclaimer

CONNECT & FOLLOW

© 10x Wealth Report Copyright 2024.